A Case of Rhabdomyolysis in a Patient with Dermatomyositis after Intravenous Injection of Gadopentetate Dimeglumine
10.3870/j.issn.1004-0781.2025.07.0025
- VernacularTitle:钆喷酸葡胺注射液致横纹肌溶解1例
- Author:
Limei LI
1
;
Wei ZUO
;
Yili SHI
Author Information
1. 中国医学科学院北京协和医院 药剂科,北京 100730;中国医学科学院北京协和医院 临床药理研究中心,北京 100730
- Publication Type:Journal Article
- Keywords:
Gadopentetate dimeglumine;
Rhabdomyolysis;
Adverse drug reaction
- From:
Herald of Medicine
2025;44(7):1169-1171
- CountryChina
- Language:Chinese
-
Abstract:
A patient with anti-MDA5-positive dermatomyositis complicated by hepatic dysfunction developed rhabdomyolysis after an intravenous injection of gadopentetate dimeglumine for magnetic resonance imaging.Analysis of clinical manifestations and medication correlation confirmed gadopentetate dimeglumineinduced rhabdomyolysis.Gadopentetate dimeglumine can cause rhabdomyolysis in dermatomyositis patients.Clinical conditions should be closely monitored when using gadopentetate dimeglumine to guard against adverse reactions.
